A practical reference on cyclic heptapeptide: what it is, how it behaves, what the literature reports, and where the honest uncertainties sit.
This page was last updated on 2026-06-29 and is reviewed periodically as new material appears.
The peptide was developed during the 1980s by researchers investigating melanocortin signalling and skin pigmentation pathways. Early work focused on analogues of alpha-melanocyte-stimulating hormone that would resist enzymatic breakdown more effectively than the parent molecule. Melanotan-2 emerged from that programme as a shortened, cyclised variant. Reports describing its synthesis and receptor activity later appeared in the scientific literature. Commercial availability grew through unregulated channels rather than through pharmaceutical approval.
Structurally, Melanotan-2 retains the core recognition motif of alpha-melanocyte-stimulating hormone while adding a lactam bridge that links two side chains and constrains the molecule into a ring. This modification lowers susceptibility to enzymatic degradation. The compound acts as an agonist at melanocortin receptors, particularly subtypes associated with melanin production. Because the same receptor family influences several physiological processes, researchers note that its activity is not confined to pigmentation alone. Receptor selectivity continues to be examined in published studies.
Melanotan-2 is a synthetic cyclic heptapeptide designed as an analogue of alpha-melanocyte-stimulating hormone, a naturally occurring peptide involved in pigmentation signalling. Its sequence incorporates modified residues that increase potency and extend biological activity relative to the native hormone. The compound binds receptors of the melanocortin family and is examined mainly in laboratory research. It does not occur naturally and exists only as a manufactured chemical entity produced by solid-phase synthesis.
The compound was developed in the late 1980s and early 1990s by academic researchers investigating melanocortin signaling and pigmentation. Early work explored whether synthetic analogs could reproduce effects of the natural hormone under controlled conditions. The molecule never advanced through the full regulatory pathway required for approval as a medicine. From the mid-2000s onward it appeared in unregulated consumer markets, often distributed through informal channels. That gap between research origins and commercial availability shapes how the compound is discussed today.
Melanotan-2 is a synthetic peptide designed as an analog of alpha-melanocyte-stimulating hormone, a signaling molecule produced in the pituitary and skin. Its structure is a linear chain of seven amino acids that folds into a ring through an internal lactam bridge joining two side chains. The compound is sometimes written as MT-II or MEL-2 in informal and commercial contexts. It belongs to the melanocortin peptide family, a group of short signaling molecules that share a conserved core sequence recognized by melanocortin receptors.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C50H69N15O9 | Synthetic cyclic heptapeptide |
| Molecular mass | Approximately 1024 g/mol | Depends on counter-ion content |
| Appearance | White to off-white powder | Commonly supplied as a lyophilised solid |
| Solubility | Freely soluble in water | Also dissolves in common aqueous buffers |
| Typical storage | -20 degrees Celsius, desiccated | Protect from light and repeated freeze-thaw |
Receptor binding at MC1R on melanocytes raises intracellular cyclic AMP and increases expression of tyrosinase and related enzymes. The downstream result is greater synthesis of eumelanin, the dark pigment, without ultraviolet exposure acting as the trigger. The compound is not selective, however, and also engages MC3R, MC4R and MC5R, which are expressed in the central nervous system and elsewhere. That lack of selectivity is the explanation usually offered for effects reported outside pigmentation, including appetite suppression and nausea. Selectivity remains a central theme in comparative studies of related peptides.
Human data remain limited and mostly short-term. Reports describe small trials and observational accounts rather than large controlled studies, so questions about dose-response relationships and long-term effects on melanocytes stay open. Whether repeated exposure alters naevus behaviour is not settled in the published record. Researchers also note that self-administered use outside clinical settings makes actual exposure difficult to quantify. Statements about efficacy and safety should therefore be read as preliminary rather than established.
Nigel Farage announces that Reform UK would preclude anyone arriving into the UK by illegal means from claiming asylum, with plans to deport 600,000 people over five years. Farage says that in order to deport 600,000 asylum seekers, a government headed by his party would leave the European Convention on Human Rights (ECHR) which may require a renegotiation of the terms of the Good Friday Agreement which has the ECHR written into it. 27 August – Former British Prime Minister Tony Blair joins a White House meeting with US President Donald Trump to discuss post-war Gaza. Liberal Democrat leader Sir Ed Davey announces he will boycott the banquet for Donald Trump's state visit to the United Kingdom in order to "send a message" over the humanitarian crisis in Gaza. Scottish Conservative MSP Graham Simpson defects to Reform UK. Farage rules out deporting children as part of Reform's deportation policy. 28 August – Starmer is to replace his principal private secretary, Nin Pandit, after ten months in the role. She follows the departures of chief of staff, Sue Gray, in October 2024 and director of communications, Matthew Doyle, in March, as the third Starmer-appointed senior staff member to be let go by him in less than a year. The UK, France and Germany begin the process of restoring UN sanctions against Iran following tension over its nuclear programme. MSP Colin Smyth has his Holyrood pass deactivated following allegations he placed a camera in a Scottish Parliament toilet.
=== Infection === Cirrhosis can cause immune system dysfunction, leading to infection. Signs and symptoms of infection may be nonspecific and are more difficult to recognize (for example, worsening encephalopathy but no fever). Moreover, infections in cirrhosis are major triggers for other complications (ascites, variceal bleeding, hepatic encephalopathy, organ failures, death). Those with cirrhosis are at increased risk of infections as well as increased mortality from infections. This is due to a combination of factors, including cirrhosis-associated immune dysfunction, reduced gut barrier function, reduced bile flow, and changes in the gut microbiota, with an increase in pathobionts (native bacteria that, under certain conditions, may cause infection). Cirrhosis associated immune dysfunction is caused by reduced complement component synthesis in the liver including C3, C4 and reduced total complement activity (CH50). The complement system is a part of the innate immune system and assists immune cells and antibodies in destroying pathogens. The liver produces complement factors, but this may be reduced in cirrhosis, raising the risk of infections. Acute phase proteins (which help mount an immune response) and soluble pattern recognition receptors (which help immune cells to identify pathogens) are also reduced in those with cirrhosis, leading to further immune dysfunction. Cirrhosis is also associated with reduced Kupfer cell function, further increasing the risk for infections. Kupfer cells are resident macrophages in the liver, which help to destroy pathogens.
== Books == The Science of Desire: The Search for the Gay Gene and the Biology of Behavior (Simon and Schuster, 1994) ISBN 0-684-80446-8 Living with Our Genes: Why They Matter More Than You Think with Peter Copeland (Anchor, 1999) ISBN 0-385-48584-0 The God Gene: How Faith Is Hardwired into our Genes (Doubleday, 2004) ISBN 0-385-50058-0
Normal barracks headdress is the sand-coloured beret; its cap badge is a downward pointing Excalibur, wreathed in flames (often incorrectly referred to as a winged dagger) worked into the cloth of a Crusader shield with the motto Who Dares Wins. SAS pattern parachute wings, designed by Lieutenant Jock Lewes and based on the stylised sacred ibis of Isis of Egyptian iconography depicted in the décor of Shepheard's Hotel in Cairo, are worn on the right shoulder. Its ceremonial No 1 dress uniform is distinguished by a light-blue stripe on the trousers. Its stable belt is a shade of blue similar to the blue stripe on the No 1 dress uniform.
[xanthine oxidase] + 2 glutathione Thus, the two substrates of this enzyme are xanthine dehydrogenase and glutathione disulfide, whereas its two products are xanthine oxidase and glutathione. This enzyme belongs to the family of oxidoreductases, specifically those acting on a sulfur group of donors with a disulfide as acceptor. The systematic name of this enzyme class is [xanthine-dehydrogenase]:glutathione-disulfide S-oxidoreductase. Other names in common use include [xanthine-dehydrogenase]:oxidized-glutathione S-oxidoreductase, enzyme-thiol transhydrogenase (oxidized-glutathione), glutathione-dependent thiol:disulfide oxidoreductase, and thiol:disulfide oxidoreductase. This enzyme participates in glutathione metabolism.
Sources: en.wikipedia.org
According to scholar Shirley Anne Tate, skin whiteners in the United States were initially predominantly used by white women. European immigrants introduced recipes for cosmetic skin lighteners into the American colonies, where they eventually evolved to incorporate indigenous and West African herbal traditions. Skin whitening grew in popularity in the 1800s, as white women in the United States began to emulate the skin-whitening practices performed by those in Europe. As such, American women similarly used ceruse, arsenic wafers, and products that contained toxic dosages of lead and mercury. Mormon denominations, like the Church of Jesus Christ of Latter-day Saints (LDS church), taught into the 1970s that God would whiten the skin color of Native American adherents, and that skin color was correlated with premortal obedience to God. In the 2015 book, Skin bleaching in Black Atlantic zones: shade shifters, author Shirley Anne Tate writes that skin lightening was often not well-received in Black culture. Women in Black cultures who used skin whiteners were described as artificial, while Black men who used skin whiteners were described as overly effeminate. Despite this reception, skin whitening remained a popular practice. Historians note that advertisements for skin whiteners in the 20th century often associated pale skin with gentility. According to historian Kathy Peiss, skin whitening among black American women had been documented starting in the mid-nineteenth century.
=== Detection of aircraft === In 1931, Arnold Frederic Wilkins joined Watt's staff in Slough. As the "new boy", he was given a variety of menial tasks to complete. One of these was to select a new shortwave receiver for ionospheric studies, a task he undertook with great seriousness. After reading everything available on several units, he selected a model from the General Post Office (GPO) that worked at (for that time) very high frequencies. As part of their tests of this system, in June 1932 the GPO published a report, No. 232 Interference by Aeroplanes. The report recounted the GPO testing team's observation that aircraft flying near the receiver caused the signal to change in intensity, an annoying effect known as fading. The stage was now set for the development of radar in the UK. Using Wilkins' knowledge that shortwave signals bounced off aircraft, a BBC transmitter to light up the sky as in Appleton's experiment, and Watt's RDF technique to measure angles, a complete radar could be built. While such a system could determine the angle to a target, it could not determine its range and provide a location in space. To do so, two such measurements would have to be made from different locations. Watt's huff-duff technique solved the problem of making rapid measurements, but the issue of coordinating the measurement at two stations remained, as did any inaccuracies in measurement or differences in calibration between the two stations.
With a population of 84.7 million according to the 2023 German census, Germany is the most populous member state of the European Union, the second-most populous country in Europe after Russia, and the nineteenth-most populous country in the world. Its population density stands at 236 inhabitants per square kilometre (610 inhabitants/mi2). The fertility rate of 1.36 children born per woman (2024 estimates) is below the replacement rate of 2.1, but slightly above the EU average of 1.34. Since the 1970s, Germany's death rate has exceeded its birth rate. However, the country is witnessing increased birth and migration rates since the early 2010s. Germany has the fourth oldest population in the world, with an average age of 47.8 years.
=== Financial issues and conflicts of interest === Ethical considerations in financial include accurate billing practices and clearly defined financial relationships. Doctors have both a professional duty and obligation under the justice principle to ensure that patients are provided the same care regardless of status or ability to pay. However, informal copayment forgiveness may have legal ramifications and the providing professional courtesy may have negatively impact care. Dotors must disclose all possible conflicts of interest including financial relationships, investments, research and referral relationships, and any other instances that may subjugate or give the appearance of subjugating patient care to self-interest.
Sources: en.wikipedia.org
It is a synthetic cyclic heptapeptide and an analogue of alpha-melanocyte-stimulating hormone. The molecule is produced by chemical synthesis rather than extracted from a biological source.
It is shorter than the native hormone and carries a cyclic constraint that improves stability. These changes raise receptor potency and slow breakdown relative to the naturally occurring peptide.
Published accounts date its development to the 1980s, when researchers were generating analogues of melanocyte-stimulating hormone. That work aimed to produce more stable compounds for studying pigmentation biology.
It is a synthetic seven-amino-acid peptide modeled on alpha-melanocyte-stimulating hormone. It carries two non-natural substitutions and a cyclic bridge that increase its stability relative to the natural hormone. It circulates as a research chemical and is not an approved medicine.